Smart Wearables for Cardiac Monitoring-Real-World Use beyond Atrial Fibrillation.
David DunckerWern Yew DingSusan EtheridgePeter A NoseworthyChristian VeltmannXiaoxi YaoT Jared BunchDhiraj GuptaPublished in: Sensors (Basel, Switzerland) (2021)
The possibilities and implementation of wearable cardiac monitoring beyond atrial fibrillation are increasing continuously. This review focuses on the real-world use and evolution of these devices for other arrhythmias, cardiovascular diseases and some of their risk factors beyond atrial fibrillation. The management of nonatrial fibrillation arrhythmias represents a broad field of wearable technologies in cardiology using Holter, event recorder, electrocardiogram (ECG) patches, wristbands and textiles. Implementation in other patient cohorts, such as ST-elevation myocardial infarction (STEMI), heart failure or sleep apnea, is feasible and expanding. In addition to appropriate accuracy, clinical studies must address the validation of clinical pathways including the appropriate device and clinical decisions resulting from the surrogate assessed.
Keyphrases
- atrial fibrillation
- st elevation myocardial infarction
- percutaneous coronary intervention
- heart failure
- sleep apnea
- oral anticoagulants
- left atrial
- catheter ablation
- risk factors
- left ventricular
- left atrial appendage
- primary care
- st segment elevation myocardial infarction
- direct oral anticoagulants
- heart rate
- cardiovascular disease
- healthcare
- acute coronary syndrome
- coronary artery disease
- congenital heart disease
- quality improvement
- obstructive sleep apnea
- case report
- cardiac surgery
- cardiovascular risk factors
- metabolic syndrome
- cardiovascular events
- blood pressure